Exelixis Clinical Site #105 — Hackensack, New Jersey

Exelixis Clinical Site #105 is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Exelixis Clinical Site #105 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC).

Sponsors: Exelixis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Hackensack

Browse all research sites in New Jersey · View every site in Hackensack

• The Cancer Center Hackensack University Medical Center
• John Theurer Cacner Center at Hackensack University Medical Center
• John Theurer Cancer Center (JTCC) at Hackensack University Medical Center (HUMC)
• Hackensack University Medical Center - Skin Laser & Surgery Specialists Of NY & NJ
• Hackensack University Medical Center Urology
• Hackensack University Medical Center SC-2
• Hackensack University Medical Center
• The John Theurer Cancer Center, Hackensack University Medical Center
• The Cancer Cener at Hackensack University Medical Center
• The Joseph M. Sanzari Children's Hospital
• John Theurer Cancer Center / Hackensack University
• Hackensack University Medical Center/Hackensack Meridian Health

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exelixis Clinical Site #105?

Exelixis Clinical Site #105 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exelixis Clinical Site #105 conducted?

Exelixis Clinical Site #105 has 1 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC).

Is Exelixis Clinical Site #105 accredited by Crixeo Clinical Trials?

Exelixis Clinical Site #105 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exelixis Clinical Site #105?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.